Tuberculosis In Texas Presentation by: Brian R. Smith, M.D., M.P.H., Regional Director.

Slides:



Advertisements
Similar presentations
Last Update: March 31, 2004 Division of Tuberculosis Control Virginia Department of Health Epidemiology of Tuberculosis in Virginia, 2002.
Advertisements

Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum.
Introduction India has the highest burden of tuberculosis in the world, with an estimated 2 million cases annually, accounting for 1/5 th of global incidence.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
TB recurrence & treatment B 陳名揚. Successful treatment more than one drug to which the organisms are susceptible appropriate doses take drugs regularly.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.
MDR and XDR TB Bruce A. Bush, M.D. Regional Tuberculosis Consultant
2014 WI TB Update WI TB Program Wisconsin Department of Health Services Pa Vang, RN, MSN WI TB Program TB Summit, 2014 WI TB Program Update.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
Tuberculosis Presented by Vivian Pham and Vivian Nguyen.
+ Tuberculosis: Quick Facts. + Tuberculosis: Reflection How does TB affect a person’s health? How does TB affect a person’s life, socially? What problem.
experience from Lesotho
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
SESSION 1: Introduction to DOT. DOT Curriculum Session 1 2 Worldwide TB Statistics 1.Approximately 8 million new cases of active TB each year 2.World.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
1 Epidemiology of Pediatric Tuberculosis in the United States, 1993–2006 Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis.
Evaluating Tuberculosis Surveillance and Action in an Urban and Rural Setting Kristine Lykens, Ph.D. In collaboration with Anita Kurian, MPH, MBBS Patrick.
PREVENTING RELAPSE Lee B. Reichman, MD, MPH Northeast TB Controllers Meeting October 24, 2006 Princeton, New Jersey.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
Abbreviations: FGD = Focus Group Discussion INH = Isoniazid IPT = Isoniazid Preventive Therapy for TB PWH = People with HIV-infection DOT = Directly observed.
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
Epidemiology of tuberculosis. Peymane Adab, Richard Fielding, Susana Castan.
Directly Observed Therapy  Prescribed by a physician and required by policy for all public and private patients  Strategy to ensure uninterrupted TB.
Progress of the Singapore TB Elimination Programme (STEP)
Division of Tuberculosis Elimination Centers for Disease Control and Prevention Tuberculosis in the United States National Tuberculosis Surveillance System.
Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2011 National Center for HIV/AIDS, Viral Hepatitis, STD, and.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Beyond Sputum Cups and Four Drugs The Responsibility of the Practicing Clinician in the Community Control of Tuberculosis V. R. Koppaka, MD, PhD Division.
Treatment and scale up access TV, ART OST treatment for people who use drug sin SEA Ekta.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 8.
Promoting Rational Use of ARVs in HIV/AIDS Clinics in Tanzania Presented by Salama Mwakisu -MSH.
Abstract Modern chemotherapy has played a major role in our control of tuberculosis. Yet tuberculosis still remains a leading infectious disease worldwide.
Tuberculosis Dr Hafsa Raheel, MBBS, MCPS, FCPS Department of Family and Community Medicine KSU.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
Contribution of operational research in China National Center for TB Control and Prevention, China CDC Jiang Shiwen Cancun.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
L.A. County Public Health Partnering with the Private Community to Control TB Myrna Mesrobian, MD, MPH.
1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam.
GALVESTON COUNTY TB PROGRAM  SYED HAIDRY TB PROGRAM MANAGER  Dr. MARK GUIDRY CEO, HEALTH AUTHORITY & TB CLINICIAN.
Predictors of Failure in Timely TB Treatment Completion, United States Carla Winston,PhD TB PEN Focal Point Open Forum June 5,
Treatment Regimens for Pulmonary Tuberculosis Caused by Drug- Susceptible Organisms Initial PhaseContinuation Phase RegimenDrugs Interval and Doses (Minimal.
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
Tuberculosis in the United States
Tuberculosis in children
Treatment of TB Disease
Tuberculosis in the United States
Tuberculosis in the United States
Tuberculosis in the United States
TUBERCULOSIS IN VIRGINIA
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
PROGRESS IN GLOBAL TB CONTROL
بسم الله الرحمن الرحيم.
Knowledge gaps in formulating TB Control Policies for Prisons
PROGRESS IN GLOBAL TB CONTROL
Improving the Use of Medications to Treat Complex Health Problems in Resource-Poor Settings: Community-Based Examples from Haiti and Peru Jennifer Furin,
The STOP TB Strategy – 2009 VISION: A TB-free world
Pharmacy Sector SECTOR COMMITMENT TO END TB
Monitoring and Evaluation: A Review of Terms
Presentation transcript:

Tuberculosis In Texas Presentation by: Brian R. Smith, M.D., M.P.H., Regional Director

The captain of all these men of death that came against him to take him away, was the Consumption, for it was that that brought him down to the grave. John Bunyan, The Life and Death of Mr. Badman

I have been sick as a dog the last two weeks. I caught a cold in spite of 18 degrees C. of heat, roses, oranges, palm, figs and the three most famous doctors on the island. One sniffed at what I spat up, the second tapped where I spat it from, the third poked about and listened how I spat it. One said I had died, the second that I am dying, the third that I shall die…All this has affected the “Preludes” and God knows when you will get them. Frédéric Chopin

Reported TB Cases United States, Year No. of Cases

TB Morbidity United States, Year Cases Rate* , , , , , *Cases per 100,000

TB Case Rates, United States, 2001 < 3.5 (year 2000 target) > 5.6 (national average) D.C. Rate: cases per 100,000

Tuberculosis in Texas Case Rate vs. D.O.T Cases per 100,000 population Percent of patients on DOT Rate Directly Observed Therapy ( D.O.T. )

Worldwide TB Concerns  Increase in incidence of TB  Increase in MDR-TB  Increase in HIV infection  Increase in immigration and travel  Increase in demand for resources  Interruptions in medicine supplies  Improper drug prescription  Non-adherence to treatment protocols

Other regional challenges in 1992  Poor reporting  No infection control in clinics or hospitals  No drug-resistant treatment  No program for consultation  Private patients not monitored; 100 % with major errors by physicians or patients not purchasing medications  Drug resistance caused by physicians using various propietary regimens or by self- prescribing

Pharmacist selling Rifampin “Farmacéutico que vende Rifampin”

A family of three generations residing along the Texas-Mexican border Matriarch of the family was prescribed INH for a positive skin test Diagnosed pulmonary TB Died of MDR TB with a final hospitalization cost of 1.5 million dollars MDR cases, plus 54 PPD-positive family contacts monitored by X-ray

X X X X Red - TB Case Green - Positive Reactor Blue - Negative PPD Blue X - PPD Refused Black - BCG D - Deceased - Unknown D D D D D D X

MDR -TB medications “Medicaciones del MDR-TB”

Cost for TB treatment “Costo para el tratamiento del TB” Cost for TB treatment “Costo para el tratamiento del TB”

Plan: focus on the key elements  DOT and completion of treatment for all public and private patients with RIPE  Thorough contact investigation and preventive treatment of contacts  Attention to high risk areas such as jails, HIV patients, shelters  Infection control in TB clinics, hospitals, and jails  Prevention of MDR by active surveillance, monitoring patients of private doctors, and consultation in all resistant cases

Directly Observed Therapy (DOT)  Non-adherence is a major problem in TB control  DOT mandatory for all Texas patients, including private pay because studies show that adherence is not related to income or education  In DOT, a health care worker watches the patient swallow each does of medication  WHO plan for TB control around the world  DOT can lead to significant reductions in relapse and acquired drug resistance  Use DOT with other measures to promote adherence

Advantages of Successful DOT  Reduces the period of infectivity  Reduces treatment failure and acquired drug-resistance  DOT is the best way to ensure that patients complete therapy  Able to count number of TB drug doses ingested DOT is the Standard of Care in Texas for all TB cases/suspects TDH policy 9/95